Stock Rich List
#2434 on the rich list of 14,644 insiders

Cameron Turtle

Chief Executive Officer at Spyre Therapeutics; Director at Oruka Therapeutics. Based in Waltham, Massachusetts.

$53.4M
in disclosed stock, −$1.8M (−3.29%) today
Live prices, last trade 2:43 PM ET
Rank
2434th of 14,644
Companies held
2
Largest holding
SYRE, 98.7% of total
Latest SEC filing
Oct 1, 2026

What the $53.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Spyre Therapeutics SYRE
Common Stock
Directly537,540$98.05$52.7M98.7%Form 4, Oct 1, 2026
Oruka Therapeutics ORKA
Common Stock
Through Turtle Family Trust7,103
split-adjusted
$98.39$699K1.3%Form 3, Aug 29, 2024

Share counts are the amounts Cameron Turtle reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 1, 2026SoldSYRE600$89.14$53KView
Oct 1, 2026SoldSYRE2,683$90.10$242KView
Oct 1, 2026SoldSYRE2,638$91.49$241KView
Oct 1, 2026SoldSYRE3,989$92.31$368KView
Oct 1, 2026SoldSYRE4,990$93.37$466KView
Oct 1, 2026SoldSYRE100$93.91$9KView
Sep 1, 2026SoldSYRE8,400$87.15$732KView
Sep 1, 2026SoldSYRE2,500$86.36$216KView
Sep 1, 2026SoldSYRE400$89.07$36KView
Sep 1, 2026SoldSYRE3,700$88.06$326KView
Aug 3, 2026SoldSYRE800$93.97$75KView
Aug 3, 2026SoldSYRE7,157$95.10$681KView
Aug 3, 2026SoldSYRE5,635$95.93$541KView
Aug 3, 2026SoldSYRE1,392$96.82$135KView
Aug 3, 2026SoldSYRE16$97.46$2KView
Jul 1, 2026SoldSYRE4,234$88.12$373KView
Jul 1, 2026SoldSYRE590$88.91$52KView
Jul 1, 2026SoldSYRE10,176$87.44$890KView
Jun 1, 2026SoldSYRE3,294$71.38$235KView
Jun 1, 2026SoldSYRE8,149$70.50$575KView
Jun 1, 2026SoldSYRE3,557$69.40$247KView
May 1, 2026SoldSYRE3,100$73.14$227KView
May 1, 2026SoldSYRE1,000$71.76$72KView
May 1, 2026SoldSYRE3,600$70.77$255KView
May 1, 2026SoldSYRE5,300$69.54$369KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2431Corie S. Barry
CEO, Best Buy Co.. Ann Arbor, MI
$53.4M−$665K (−1.23%)
2432Ganesh Moorthy
PRESIDENT AND CEO, Microchip Technology. Malta, NY
$53.4M+$354K (+0.67%)
2433Robert Soderbery
EVP & GM, Flash Business, Western Digital. Milwaukee, WI
$53.4M+$2.0M (+3.94%)
2434Cameron Turtle
Chief Executive Officer, Spyre Therapeutics. Waltham, MA
$53.4M−$1.8M (−3.29%)
2435Paul M. Donofrio
Vice Chair, Bank of America. Charlotte, NC
$53.4M−$263K (−0.49%)
2436W. Blake Baird
CHAIRMAN AND CEO, Terreno Realty. Bellevue, WA
$53.4M−$880K (−1.62%)
2437John B. Wood
Chairman and CEO, Telos. Ashburn, VA
$53.4M+$921K (+1.75%)

Other Spyre Therapeutics insiders

All SYRE insiders

Questions

How much stock does Cameron Turtle own?

Cameron Turtle holds $53,404,637 in listed stock based on SEC filings and current prices, mostly Spyre Therapeutics (SYRE). That ranks 2434th on the Stock Rich List.

Is this Cameron Turtle's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Cameron Turtle last buy or sell stock?

The most recent open-market trade on file is a sale of 600 SYRE shares on Oct 1, 2026 at $89.14.